Application of computerized cognitive test battery in major depressive disorder: a narrative literature review

References

• GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392:1789–1858.
   PubMed Web of Science ®Google Scholar
• Otte C, Gold SM, Penninx BW, et al. Major depressive disorder. Nat Rev Dis Primers. 2016;2:16065.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–224.
   PubMed Web of Science ®Google Scholar
• VanderWeele TJ. Challenges estimating total lives lost in COVID-19 decisions: consideration of mortality related to unemployment, social isolation, and depression. JAMA. 2020;324(5):445–446.
   PubMed Web of Science ®Google Scholar
• Tsujii N, Mikawa W, Adachi T, et al. Right prefrontal function and coping strategies in patients with remitted major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2020;108:110085.
   PubMed Web of Science ®Google Scholar
• Lam RW, Kennedy SH, McLntyre RS, et al. Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Can J Psychiatry. 2014;59(12):649–654.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Cha DS, Soczynska JK, et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 2013;30(6):515–527.
   PubMed Web of Science ®Google Scholar
• Semkovska M, Quinlivan L, O’Grady T, et al. Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(10):851–861.
   PubMed Web of Science ®Google Scholar
• Dannlowski U, Kugel H, Grotegerd D, et al. NCAN cross-disorder risk variant is associated with limbic gray matter deficits in healthy subjects and major depression. Neuropsychopharmacology. 2015;40(11):2510–2516.
   PubMed Web of Science ®Google Scholar
• Schulz KP, Li X, Clerkin SM, et al. Prefrontal and parietal correlates of cognitive control related to the adult outcome of attention-deficit/hyperactivity disorder diagnosed in childhood. Cortex. 2017;90:1–11.
   PubMed Web of Science ®Google Scholar
• McDermott LM, Ebmeier KP. A Meta-analysis of depression severity and cognitive function. J Affect Disord. 2009;119(1–3):1–8.
   PubMed Web of Science ®Google Scholar
• Chen C, Jiang W-H, Wang W, et al. Impaired visual, working, and verbal memory in first-episode, drug-naive patients with major depressive disorder in a Chinese population. PLoS One. 2018;13(4):e0196023.
   PubMed Web of Science ®Google Scholar
• Pan Z, Park C, Brietzke E, et al. Cognitive impairment in major depressive disorder. CNS Spectr. 2019;24(1):22–29.
   PubMed Web of Science ®Google Scholar
• Pu M, Wang X, Zhang J. Impact of GRIK4 gene polymorphisms on cognitive dysfunction in patients with major depression. Rev Neurol (Paris). 2020;176(10):823–828.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczynska JZ, Woldeyohannes HO, et al. The impact of cognitive impairment on perceived workforce performance: results from the international mood disorders collaborative project. Compr Psychiatry. 2015;56:279–282.
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Greer TL. Cognitive dysfunction in unipolar depression: implications for treatment. J Affect Disord. 2014;152–154:19–27.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu B, Wang M, et al. Evidence for progressive cognitive deficits in patients with major depressive disorder. Front Psychiatry. 2021;12:627695.
   PubMed Web of Science ®Google Scholar
• Ulbricht CM, Rothschild AJ, Lapane KL. Functional impairment and changes in depression subtypes for women in STAR*D: a latent transition analysis. J Womens Health. 2016;25(5):464–472.
   Web of Science ®Google Scholar
• Russo M, Mahon K, Burdick KE. Measuring cognitive function in MDD: emerging assessment tools. Depress Anxiety. 2015;32(4):262–269.
   PubMed Web of Science ®Google Scholar
• Zheng F, Zhong B, Song X, et al. Persistent depressive symptoms and cognitive decline in older adults. Br J Psychiatry. 2018;213(5):638–644.
   PubMed Web of Science ®Google Scholar
• Culpepper L, Lam RW, McIntyre RS. Cognitive impairment in patients with depression: awareness, assessment, and management. J Clin Psychiatry. 2017;78(9):1383–1394.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Florea I, Tonnoir B, et al. Efficacy of vortioxetine on cognitive functioning in working patients with major depressive disorder. J Clin Psychiatry. 2017;78(01):115–121.
   PubMedGoogle Scholar
• McIntyre RS, Anderson N, Baune BT, et al. Expert consensus on screening and assessment of cognition in psychiatry. CNS Spectr. 2019;24(1):154–162.
   PubMed Web of Science ®Google Scholar
• Ragguett R-M, Cha DS, Kakar R, et al. Assessing and measuring cognitive function in major depressive disorder. Evid Based Ment Health. 2016;19(4):106–109.
   PubMed Web of Science ®Google Scholar
• Iverson GL, Lam RW. Rapid screening for perceived cognitive impairment in major depressive disorder. Ann Clin Psychiatry. 2013;25(2):135–140.
   PubMed Web of Science ®Google Scholar
• Delis DC, Freeland J, Kramer JH, et al. Integrating clinical assessment with cognitive neuroscience: construct validation of the California verbal learning test. J Consult Clin Psychol. 1988;56(1):123–130.
   PubMed Web of Science ®Google Scholar
• Jaeger J, Domingo SZ. The digit symbol substitution test (DSST): psychometric properties and clinical utility in major depressive disorder. Eur Neuropsychopharmacol. 2016;2:S341.
   Google Scholar
• Srisurapanont M, Eurviriyanukul K, Suttajit S, et al. Internal consistency and concurrent validity of the Montreal Cognitive Assessment in individuals with major depressive disorder. Psychiatry Res. 2017;253:333–337.
   PubMed Web of Science ®Google Scholar
• Fehnel SE, Forsyth BH, DiBenedetti DB, et al. Patient-centered assessment of cognitive symptoms of depression. CNS Spectr. 2016;21(1):43–52.
   PubMed Web of Science ®Google Scholar
• Shi C, Wang G, Tian F, et al. Reliability and validity of Chinese version of perceived deficits questionnaire for depression in patients with MDD. Psychiatry Res. 2017;252:319–324.
   PubMed Web of Science ®Google Scholar
• Levada OA, Troyan AS. Cognitive-functional relationships in major depressive disorder: crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram. J Affect Disord. 2019;250:114–122.
   PubMed Web of Science ®Google Scholar
• Ott CV, Bjertrup AJ, Jensen JH, et al. Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools. J Affect Disord. 2016;190:607–615.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Womer FY, Leng H, et al. The relationship between cognitive dysfunction and symptom dimensions across schizophrenia, bipolar disorder, and major depressive disorder. Front Psychiatry. 2019;10:253.
   PubMed Web of Science ®Google Scholar
• Fava M, Iosifescu DV, Pedrelli P, et al. Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire. Psychother Psychosom. 2009;78(2):91–97.
   PubMed Web of Science ®Google Scholar
• Cornblatt BA, Risch NJ, Faris G, et al. The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res. 1988;26(2):223–238.
   PubMed Web of Science ®Google Scholar
• Han G, Klimes-Dougan B, Jepsen S, et al. Selective neurocognitive impairments in adolescents with major depressive disorder. J Adolesc. 2012;35(1):11–20.
   PubMed Web of Science ®Google Scholar
• Kertzman S, Reznik I, Hornik-Lurie T, et al. Stroop performance in major depression: Selective attention impairment or psychomotor slowness? J Affect Disord. 2010;122(1–2):167–173.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Lophaven S, Olsen CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharm. 2014;17(10):1557–1567.
   PubMed Web of Science ®Google Scholar
• Liang S, Yu W, Ma X, et al. Psychometric properties of the MATRICS Consensus Cognitive Battery (MCCB) in Chinese patients with major depressive disorder. J Affect Disord. 2020;265:132–138.
   PubMed Web of Science ®Google Scholar
• Mahableshwarkar AR, Zajecka J, Jacobson W, et al. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacol. 2015;40(8):2025–2037.
   PubMed Web of Science ®Google Scholar
• Cotrena C, Branco LD, Shansis FM, et al. Executive function impairments in depression and bipolar disorder: association with functional impairment and quality of life. J Affect Disord. 2016;190:744–753.
   PubMed Web of Science ®Google Scholar
• Sneed JR, Roose SP, Keilp JG, et al. Response inhibition predicts poor antidepressant treatment response in very old depressed patients. Am J Geriatr Psychiatry. 2007;15(7):553–563.
   PubMed Web of Science ®Google Scholar
• Rose EJ, Ebmeier K. Pattern of impaired working memory during major depression. Journal of Affective Disorders. 2006;90(2–3):149–161.
   PubMed Web of Science ®Google Scholar
• Soczynska JK, Ravindran LN, Styra R, et al. The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: results from a randomized controlled trial. Psychiatry Res. 2014;220(1–2):245–250.
   PubMed Web of Science ®Google Scholar
• Malloy-Diniz LF, Lasmar VAP, Gazinelli L. D S R, et al. The Rey auditory-verbal learning test: applicability for the Brazilian elderly population. Braz J Psychiatry. 2007;29(4):324–329.
   PubMed Web of Science ®Google Scholar
• Benedict RHB, Schretlen D, Groninger L, et al. Hopkins verbal learning test – revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12(1):43–55.
   Web of Science ®Google Scholar
• Bakkour N, Samp J, Akhras K, et al. Systematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorder. Psychiatry Res. 2014;216(3):291–302.
   PubMed Web of Science ®Google Scholar
• Moirand R, Galvao F, Lecompte M, et al. Usefulness of the montreal cognitive assessment (MoCA) to monitor cognitive impairments in depressed patients receiving electroconvulsive therapy. Psychiatry Res. 2018;259:476–481.
   PubMed Web of Science ®Google Scholar
• MacQueen GM, Memedovich KA. Cognitive dysfunction in major depression and bipolar disorder: a ssessment and treatment options. Psychiatry Clin Neurosci. 2017;71(1):18–27.
   PubMed Web of Science ®Google Scholar
• Bora E, Harrison BJ, Yücel M, et al. 2013. Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med. 2013;43:2017–2026.
   PubMed Web of Science ®Google Scholar
• Bortolato B, F, Carvalho A, S, McIntyre R. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review. CNS Neurol Disord Drug Targets. 2014;13:1804–1818.
   PubMed Web of Science ®Google Scholar
• Bauer RM, Iverson GL, Cernich AN, et al. Computerized neuropsychological assessment devices: joint position paper of the American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology. Clin Neuropsychol. 2012;26(2):177–196.
   PubMed Web of Science ®Google Scholar
• Mohn C, Rund BR. Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints. BMC Psychiatry. 2016;16:108.
   PubMed Web of Science ®Google Scholar
• Roebuck-Spencer TM, Glen T, Puente AE, et al. Cognitive screening tests versus comprehensive neuropsychological test batteries: a national academy of neuropsychology education Paper†. Arch Clin Neuropsychol. 2017;32(4):491–498.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Lee Y, Carmona NE, et al. Characterizing, assessing, and treating cognitive dysfunction in major depressive disorder. Harv Rev Psychiatry. 2018;26(5):241–249.
   PubMed Web of Science ®Google Scholar
• BinDhim NF, Shaman AM, Trevena L, et al. Depression screening via a smartphone app: cross-country user characteristics and feasibility. J Am Med Inform Assoc. 2015;22(1):29–34.
   PubMed Web of Science ®Google Scholar
• Robbins TW, James M, Owen AM, et al. Cambridge neuropsychological test automated battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dement Geriatr Cogn Disord. 1994;5(5):266–281.
   Google Scholar
• Sanchez-Carro Y, Portella MJ, Leal-Leturia I, et al. Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder. J Affect Disord. 2021;279:343–352.
   PubMed Web of Science ®Google Scholar
• Lam RW, Iverson GL, Evans VC, et al. The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder. J Affect Disord. 2016;203:55–61.
   PubMed Web of Science ®Google Scholar
• Davis MT, DellaGioia N, Matuskey D, et al. Preliminary evidence concerning the pattern and magnitude of cognitive dysfunction in major depressive disorder using cogstate measures. J Affect Disord. 2017;218:82–85.
   PubMed Web of Science ®Google Scholar
• Galletly C, Gill S, Rigby A, et al. Assessing the effects of repetitive transcranial magnetic stimulation on cognition in major depressive disorder using computerized cognitive testing. J ECT. 2016;32(3):169–173.
   PubMed Web of Science ®Google Scholar
• Domen AC, Weijer SCF, Jaspers MW, et al. The validation of a new online cognitive assessment tool: the MyCognition quotient. Int J Methods Psychiatr Res. 2019;28(3):e1775.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Best MW, Bowie CR, et al. The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: validation in patients with major depressive disorder. J Clin Psychiatry. 2017;78(7):873–881.
   PubMed Web of Science ®Google Scholar
• Cormack F, McCue M, Taptiklis N, et al. Wearable technology for high-frequency cognitive and mood assessment in major depressive disorder: longitudinal observational study. JMIR Ment Health. 2019;6(11):e12814.
   PubMed Web of Science ®Google Scholar
• Memória CM, Yassuda MS, Nakano EY, et al. Contributions of the computer-administered neuropsychological screen for mild cognitive impairment (CANS-MCI) for the diagnosis of MCI in Brazil. Int Psychogeriatr. 2014;26(9):1483–1491.
   Web of Science ®Google Scholar
• Ladegaard N, Larsen ER, Videbech P, et al. Higher-order social cognition in first-episode major depression. Psychiatry Res. 2014;216(1):37–43.
   PubMed Web of Science ®Google Scholar
• Soares FC, de Oliveira TC, de Macedo LD, et al. CANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative study. Clin Interv Aging. 2015;10:37–48.
   PubMedGoogle Scholar
• Mielke MM, Machulda MM, Hagen CE, et al. Performance of the CogState computerized battery in the Mayo clinic study on aging. Alzheimers Dement. 2015;11(11):1367–1376.
   PubMed Web of Science ®Google Scholar
• Paul RH, Lawrence J, Williams LM, et al. Preliminary validity of “integneuroTM”: a new computerized battery of neurocognitive tests. Int J Neurosci. 2005;115(11):1549–1567.
   PubMed Web of Science ®Google Scholar
• Shilyansky C, Williams LM, Gyurak A, et al. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. Lancet Psychiatry. 2016;3(5):425–435.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Subramaniapillai M, Park C, et al. The THINC-it tool for cognitive assessment and measurement in major depressive disorder: sensitivity to change. Front Psychiatry. 2020;11:546.
   PubMed Web of Science ®Google Scholar
• Harrison JE, Barry H, Baune BT, et al. Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: a psychometric exploration in healthy volunteers. Int J Methods Psychiatr Res. 2018;27(3):e1736.
   PubMed Web of Science ®Google Scholar
• Chakrabarty T, Harkness KL, McInerney SJ, et al. Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report. Psychol Med. 2020;50(15):2536–2547.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Lee Y, Rong C, et al. Ecological momentary assessment of depressive symptoms using the mind.me application: convergence with the patient health questionnaire-9 (PHQ-9). J Psychiatr Res. 2021;135:311–317.
   PubMed Web of Science ®Google Scholar